Posts

Yarrow raises $150M

on

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50 Million

on

AusperBio raises $120 million to advance hepatitis B therapy toward Phase 3 and commercialization

on

Redx tries again at reverse merger with Skye, as alternative route gains steam

on

BlossomHill eyes IPO as fertilizer to grow taller in crowded cancer fields

on

PureTech Spins Off Celea with $180M Funding to Advance IPF Drug Deupirfenidone into Phase 3

on

Apogee bags $1.3B Blackstone royalty funding deal to push eczema challenger into phase 3

on

Full-Life Technologies Raises $150M to Accelerate Clinical Assets and Manufacturing

on

Revolution Medicines Secures $2B Funding from Royalty Pharma for RAS Cancer Drugs as Biotech Sector Heats Up

on

Obsidian Therapeutics Goes Public Through Galera Reverse Merger with $350M PIPE Financing

on

Rakovina Therapeutics Q3 2025 Financial Results and Corporate Update

on

Immunovant Announces Pricing of $550 Million Common Stock Financing

on

Apple Tree files for bankruptcy as it seeks fresh funding from Russian billionaire backer

on

Eli Lilly to Acquire Adverum Biotechnologies in Gene Therapy Deal; Captain T Cell Secures €20M Funding

on

Funding Drought Puts Pressure on Cell Therapy Startups Like Appia Bio

on

Nimble radiopharma biotech Actithera secures $75M Series A to enter the clinic

on

Sanofi backs $90M financing for I&I biologic developer

on